nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—Dry eye—Doxorubicin—bone cancer	0.00528	0.0053	CcSEcCtD
Acebutolol—Flatulence—Cisplatin—bone cancer	0.00518	0.0052	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Methotrexate—bone cancer	0.00508	0.00509	CcSEcCtD
Acebutolol—Visual disturbance—Methotrexate—bone cancer	0.00506	0.00507	CcSEcCtD
Acebutolol—Abnormal vision—Doxorubicin—bone cancer	0.00499	0.005	CcSEcCtD
Acebutolol—Eye pain—Epirubicin—bone cancer	0.00497	0.00498	CcSEcCtD
Acebutolol—Vision blurred—Cisplatin—bone cancer	0.00496	0.00497	CcSEcCtD
Acebutolol—Cardiac failure congestive—Epirubicin—bone cancer	0.00495	0.00496	CcSEcCtD
Acebutolol—Lethargy—Methotrexate—bone cancer	0.00489	0.00491	CcSEcCtD
Acebutolol—Ill-defined disorder—Cisplatin—bone cancer	0.00488	0.00489	CcSEcCtD
Acebutolol—Hot flush—Epirubicin—bone cancer	0.00479	0.00481	CcSEcCtD
Acebutolol—Menopausal symptoms—Epirubicin—bone cancer	0.00475	0.00477	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Epirubicin—bone cancer	0.00475	0.00477	CcSEcCtD
Acebutolol—Malaise—Cisplatin—bone cancer	0.00474	0.00476	CcSEcCtD
Acebutolol—Eye pain—Doxorubicin—bone cancer	0.0046	0.00461	CcSEcCtD
Acebutolol—Cardiac failure—Epirubicin—bone cancer	0.0046	0.00461	CcSEcCtD
Acebutolol—Lethargy—Epirubicin—bone cancer	0.00458	0.00459	CcSEcCtD
Acebutolol—Cardiac failure congestive—Doxorubicin—bone cancer	0.00458	0.00459	CcSEcCtD
Acebutolol—Mood swings—Methotrexate—bone cancer	0.00454	0.00455	CcSEcCtD
Acebutolol—Pain in extremity—Epirubicin—bone cancer	0.00449	0.0045	CcSEcCtD
Acebutolol—Myalgia—Cisplatin—bone cancer	0.00448	0.00449	CcSEcCtD
Acebutolol—Anxiety—Cisplatin—bone cancer	0.00446	0.00448	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00445	0.00446	CcSEcCtD
Acebutolol—Hot flush—Doxorubicin—bone cancer	0.00444	0.00445	CcSEcCtD
Acebutolol—Discomfort—Cisplatin—bone cancer	0.00442	0.00444	CcSEcCtD
Acebutolol—Affect lability—Epirubicin—bone cancer	0.00441	0.00443	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Doxorubicin—bone cancer	0.0044	0.00441	CcSEcCtD
Acebutolol—Menopausal symptoms—Doxorubicin—bone cancer	0.0044	0.00441	CcSEcCtD
Acebutolol—Oedema—Cisplatin—bone cancer	0.00429	0.00431	CcSEcCtD
Acebutolol—Cardiac failure—Doxorubicin—bone cancer	0.00425	0.00427	CcSEcCtD
Acebutolol—Mood swings—Epirubicin—bone cancer	0.00425	0.00426	CcSEcCtD
Acebutolol—Lethargy—Doxorubicin—bone cancer	0.00423	0.00425	CcSEcCtD
Acebutolol—Nervous system disorder—Cisplatin—bone cancer	0.00421	0.00422	CcSEcCtD
Acebutolol—Skin disorder—Cisplatin—bone cancer	0.00417	0.00418	CcSEcCtD
Acebutolol—Pain in extremity—Doxorubicin—bone cancer	0.00415	0.00416	CcSEcCtD
Acebutolol—Hyperhidrosis—Cisplatin—bone cancer	0.00415	0.00416	CcSEcCtD
Acebutolol—Orthostatic hypotension—Epirubicin—bone cancer	0.0041	0.00411	CcSEcCtD
Acebutolol—Anorexia—Cisplatin—bone cancer	0.00409	0.0041	CcSEcCtD
Acebutolol—Affect lability—Doxorubicin—bone cancer	0.00408	0.0041	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00404	0.00405	CcSEcCtD
Acebutolol—Hypotension—Cisplatin—bone cancer	0.00401	0.00402	CcSEcCtD
Acebutolol—Mood swings—Doxorubicin—bone cancer	0.00393	0.00394	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00391	0.00392	CcSEcCtD
Acebutolol—Dysuria—Methotrexate—bone cancer	0.00387	0.00389	CcSEcCtD
Acebutolol—Paraesthesia—Cisplatin—bone cancer	0.00385	0.00387	CcSEcCtD
Acebutolol—Dyspnoea—Cisplatin—bone cancer	0.00383	0.00384	CcSEcCtD
Acebutolol—Erectile dysfunction—Methotrexate—bone cancer	0.00381	0.00383	CcSEcCtD
Acebutolol—Orthostatic hypotension—Doxorubicin—bone cancer	0.00379	0.0038	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00374	0.00375	CcSEcCtD
Acebutolol—Decreased appetite—Cisplatin—bone cancer	0.00373	0.00374	CcSEcCtD
Acebutolol—Pneumonia—Methotrexate—bone cancer	0.00371	0.00373	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Cisplatin—bone cancer	0.00371	0.00372	CcSEcCtD
Acebutolol—Drowsiness—Methotrexate—bone cancer	0.00369	0.0037	CcSEcCtD
Acebutolol—Depression—Methotrexate—bone cancer	0.00368	0.00369	CcSEcCtD
Acebutolol—Pain—Cisplatin—bone cancer	0.00367	0.00368	CcSEcCtD
Acebutolol—Dysuria—Epirubicin—bone cancer	0.00362	0.00364	CcSEcCtD
Acebutolol—Conjunctivitis—Methotrexate—bone cancer	0.00359	0.0036	CcSEcCtD
Acebutolol—Sweating—Methotrexate—bone cancer	0.00354	0.00355	CcSEcCtD
Acebutolol—Feeling abnormal—Cisplatin—bone cancer	0.00354	0.00355	CcSEcCtD
Acebutolol—Weight increased—Epirubicin—bone cancer	0.00353	0.00354	CcSEcCtD
Acebutolol—Pneumonia—Epirubicin—bone cancer	0.00348	0.00349	CcSEcCtD
Acebutolol—Drowsiness—Epirubicin—bone cancer	0.00346	0.00347	CcSEcCtD
Acebutolol—Agranulocytosis—Methotrexate—bone cancer	0.00345	0.00346	CcSEcCtD
Acebutolol—Body temperature increased—Cisplatin—bone cancer	0.00339	0.0034	CcSEcCtD
Acebutolol—Conjunctivitis—Epirubicin—bone cancer	0.00336	0.00337	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—bone cancer	0.00335	0.00336	CcSEcCtD
Acebutolol—Sweating—Epirubicin—bone cancer	0.00331	0.00332	CcSEcCtD
Acebutolol—Pharyngitis—Methotrexate—bone cancer	0.00329	0.0033	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—bone cancer	0.00326	0.00327	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—bone cancer	0.00323	0.00324	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—bone cancer	0.00322	0.00323	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—bone cancer	0.0032	0.00321	CcSEcCtD
Acebutolol—Visual impairment—Methotrexate—bone cancer	0.0032	0.0032	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—bone cancer	0.00316	0.00317	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—bone cancer	0.00311	0.00312	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—bone cancer	0.00311	0.00312	CcSEcCtD
Acebutolol—Tinnitus—Methotrexate—bone cancer	0.00309	0.0031	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—bone cancer	0.00309	0.0031	CcSEcCtD
Acebutolol—Asthenia—Cisplatin—bone cancer	0.00308	0.00309	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—bone cancer	0.00308	0.00309	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—bone cancer	0.00307	0.00308	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—bone cancer	0.00305	0.00306	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—bone cancer	0.00301	0.00302	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—bone cancer	0.00299	0.003	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—bone cancer	0.00299	0.003	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—bone cancer	0.00298	0.00299	CcSEcCtD
Acebutolol—Chills—Methotrexate—bone cancer	0.00297	0.00298	CcSEcCtD
Acebutolol—Diarrhoea—Cisplatin—bone cancer	0.00294	0.00295	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—bone cancer	0.00293	0.00294	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—bone cancer	0.00292	0.00293	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—bone cancer	0.00289	0.0029	CcSEcCtD
Acebutolol—Flushing—Epirubicin—bone cancer	0.00288	0.00289	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—bone cancer	0.00288	0.00289	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—bone cancer	0.00286	0.00287	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—bone cancer	0.00285	0.00286	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—bone cancer	0.00282	0.00283	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—bone cancer	0.00282	0.00282	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—bone cancer	0.0028	0.0028	CcSEcCtD
Acebutolol—Back pain—Methotrexate—bone cancer	0.00279	0.0028	CcSEcCtD
Acebutolol—Chills—Epirubicin—bone cancer	0.00278	0.00279	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—bone cancer	0.00277	0.00278	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—bone cancer	0.00274	0.00275	CcSEcCtD
Acebutolol—Vomiting—Cisplatin—bone cancer	0.00273	0.00274	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—bone cancer	0.00272	0.00273	CcSEcCtD
Acebutolol—Rash—Cisplatin—bone cancer	0.00271	0.00271	CcSEcCtD
Acebutolol—Dermatitis—Cisplatin—bone cancer	0.0027	0.00271	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—bone cancer	0.00268	0.00269	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—bone cancer	0.00266	0.00267	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—bone cancer	0.00266	0.00267	CcSEcCtD
Acebutolol—Back pain—Epirubicin—bone cancer	0.00261	0.00262	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—bone cancer	0.0026	0.00261	CcSEcCtD
Acebutolol—Malaise—Methotrexate—bone cancer	0.0026	0.00261	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—bone cancer	0.00259	0.0026	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—bone cancer	0.00259	0.0026	CcSEcCtD
Acebutolol—Chills—Doxorubicin—bone cancer	0.00258	0.00258	CcSEcCtD
Acebutolol—Nausea—Cisplatin—bone cancer	0.00255	0.00256	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—bone cancer	0.00255	0.00255	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Acebutolol—Cough—Methotrexate—bone cancer	0.00252	0.00253	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—bone cancer	0.00246	0.00247	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—bone cancer	0.00246	0.00246	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—bone cancer	0.00246	0.00246	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—bone cancer	0.00246	0.00246	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00244	0.00245	CcSEcCtD
Acebutolol—Malaise—Epirubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—bone cancer	0.00243	0.00244	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Acebutolol—Syncope—Epirubicin—bone cancer	0.00242	0.00243	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—bone cancer	0.00242	0.00242	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—bone cancer	0.00239	0.00239	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—bone cancer	0.00238	0.00238	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—bone cancer	0.00237	0.00238	CcSEcCtD
Acebutolol—Cough—Epirubicin—bone cancer	0.00236	0.00236	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—bone cancer	0.00236	0.00236	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—bone cancer	0.00232	0.00233	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—bone cancer	0.00231	0.00232	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—bone cancer	0.0023	0.00231	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—bone cancer	0.0023	0.00231	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—bone cancer	0.0023	0.00231	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—bone cancer	0.00229	0.0023	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—bone cancer	0.00229	0.00229	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00228	0.00229	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—bone cancer	0.00228	0.00228	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—bone cancer	0.00227	0.00228	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—bone cancer	0.00225	0.00226	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—bone cancer	0.00225	0.00225	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—bone cancer	0.00224	0.00225	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—bone cancer	0.00222	0.00223	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—bone cancer	0.00221	0.00222	CcSEcCtD
Acebutolol—Oedema—Epirubicin—bone cancer	0.0022	0.00221	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—bone cancer	0.0022	0.00221	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—bone cancer	0.0022	0.0022	CcSEcCtD
Acebutolol—Cough—Doxorubicin—bone cancer	0.00218	0.00219	CcSEcCtD
Acebutolol—Shock—Epirubicin—bone cancer	0.00217	0.00218	CcSEcCtD
Acebutolol—Bisoprolol—CYP3A4—bone cancer	0.00216	0.713	CrCbGaD
Acebutolol—Nervous system disorder—Epirubicin—bone cancer	0.00216	0.00217	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00215	0.00215	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—bone cancer	0.00214	0.00215	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—bone cancer	0.00213	0.00214	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—bone cancer	0.00213	0.00214	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—bone cancer	0.00212	0.00213	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—bone cancer	0.00212	0.00212	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00211	0.00212	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—bone cancer	0.0021	0.00211	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—bone cancer	0.0021	0.00211	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—bone cancer	0.0021	0.00211	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—bone cancer	0.00209	0.0021	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—bone cancer	0.00207	0.00208	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—bone cancer	0.00206	0.00207	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—bone cancer	0.00205	0.00205	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—bone cancer	0.00204	0.00205	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—bone cancer	0.00203	0.00204	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—bone cancer	0.00203	0.00204	CcSEcCtD
Acebutolol—Pain—Methotrexate—bone cancer	0.00201	0.00202	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Acebutolol—Shock—Doxorubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—bone cancer	0.002	0.00201	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—bone cancer	0.00199	0.002	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—bone cancer	0.00198	0.00199	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—bone cancer	0.00198	0.00199	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—bone cancer	0.00197	0.00198	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—bone cancer	0.00197	0.00197	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—bone cancer	0.00196	0.00197	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—bone cancer	0.00194	0.00195	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—bone cancer	0.00194	0.00195	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—bone cancer	0.00194	0.00195	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—bone cancer	0.00193	0.00193	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—bone cancer	0.0019	0.00191	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—bone cancer	0.0019	0.00191	CcSEcCtD
Acebutolol—Pain—Epirubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Acebutolol—Constipation—Epirubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—bone cancer	0.00187	0.00188	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—bone cancer	0.00186	0.00187	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—bone cancer	0.00186	0.00187	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00186	0.00186	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—bone cancer	0.00184	0.00185	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—bone cancer	0.00183	0.00184	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—bone cancer	0.00181	0.00182	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—bone cancer	0.0018	0.00181	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—bone cancer	0.00177	0.00178	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00176	0.00177	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—bone cancer	0.00175	0.00176	CcSEcCtD
Acebutolol—Pain—Doxorubicin—bone cancer	0.00174	0.00175	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—bone cancer	0.00174	0.00175	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—bone cancer	0.00174	0.00175	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—bone cancer	0.00174	0.00175	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—bone cancer	0.00169	0.0017	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—bone cancer	0.00168	0.00169	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—bone cancer	0.00167	0.00167	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—bone cancer	0.00167	0.00167	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—bone cancer	0.00162	0.00163	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—bone cancer	0.00161	0.00162	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—bone cancer	0.00161	0.00162	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—bone cancer	0.00161	0.00162	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—bone cancer	0.00158	0.00159	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—bone cancer	0.00156	0.00156	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—bone cancer	0.0015	0.0015	CcSEcCtD
Acebutolol—Rash—Methotrexate—bone cancer	0.00149	0.00149	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—bone cancer	0.00148	0.00149	CcSEcCtD
Acebutolol—Headache—Methotrexate—bone cancer	0.00148	0.00148	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—bone cancer	0.00146	0.00147	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—bone cancer	0.00144	0.00145	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—bone cancer	0.0014	0.00141	CcSEcCtD
Acebutolol—Nausea—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Acebutolol—Rash—Epirubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Acebutolol—Headache—Epirubicin—bone cancer	0.00138	0.00139	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Acebutolol—Nausea—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Acebutolol—Rash—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—bone cancer	0.00128	0.00129	CcSEcCtD
Acebutolol—Headache—Doxorubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—bone cancer	0.00121	0.00122	CcSEcCtD
Acebutolol—Propranolol—CYP3A4—bone cancer	0.000874	0.288	CrCbGaD
